9NAGAI T,TOMIZAMA T,MOR IM.Effect of pancreatic elastase on diabetic nephropathy [J].Diabetes Care ,2003,8(10) : 1212.
10KEANE W F,ZHANG Z,LVLE P A,et al.Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy:the RENAAL study[J].Clin J Am Soc Nephrol,2006,1(4):761-767.
5Klahr S,Morrissey J.AngiotensinⅡand gene expression in the kidney.Am J Kidney DIs,2008,31:17-176.
6Alter ML,Ott IM, yon Websky K, et a l. DPP-4 inhibition on top of angiotensin receptor blockade offers a new therapeutic approach for diabetic nephropathy [J]. Kidney Blood Press Res, 2012, 36 (1):119- 130.
7Zhang X. Therapeutic effects of calcium dobesilate on diabetic ne phropathy mediated through reduction of expression of PAI-1 [J]. Exp Ther Med, 2{)13,5 ( 1 ) : 295-299.
8Hebert LA. Optimizing ACE inhibitor therapy for chronic kidney disease[J]. N Engl J Med,2006,345(2) : 189-191.
9Ghorbani A, Omidvar B, Beladi-Mousavi SS, et al. The effect of pentoxifylline on reduction of proteinuria among patients with type 2 diabetes under blockade of angiotensin system: a double blind and randomized clinical trial [J]. Nefrologia, 2(112,32 (6): 790- 796.
10Suganami T,Mukoyamma M,Sugawara A,et al.Over-expression of brain natriuretic peptide in mice ameliorates immune-mediated renal injury [J]. J Am Soc Nephrol,2001, 12(12):2652-2657.
